This is an old revision of this page, as edited by Alvin Seville (talk | contribs) at 08:19, 30 September 2010 (removing and categorizing). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 08:19, 30 September 2010 by Alvin Seville (talk | contribs) (removing and categorizing)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Identifiers | |
|---|---|
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.778  |
| Chemical and physical data | |
| Formula | C16H16N2O2 |
| Molar mass | 268.310 g/mol g·mol |
| 3D model (JSmol) | |
SMILES
| |
DMeOB is a drug used in scientific research which acts as a negative allosteric modulator of the metabotropic glutamate receptor subtype mGluR5.
References
- O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL (2003). "A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5". Molecular Pharmacology. 64 (3): 731–40. doi:10.1124/mol.64.3.731. PMID 12920211.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |